GLP-1 Drugs Expand Beyond Weight Loss, but Evidence Gaps Demand Caution
Semaglutide and tirzepatide drive drugs like Ozempic and Wegovy. They have rapidly moved past their original uses. Researchers now…
Semaglutide and tirzepatide drive drugs like Ozempic and Wegovy. They have rapidly moved past their original uses. Researchers now…
Glucagon-like peptide-1 receptor agonists may enhance several aspects of cancer treatment, according to five real-world studies that will be…
Obesity treatment has entered a critical new phase. Injectable medications like semaglutide and tirzepatide now achieve weight loss between…
Bile acid malabsorption affects about 1% of the general population. This condition causes chronic and socially difficult symptoms. Patients…
GLP-1 receptor agonists have fundamentally changed how medical professionals treat obesity and type 2 diabetes. Popular medications like semaglutide…
Many people face constant thoughts about eating throughout the day. Doctors call this experience food noise. These thoughts often…
A National Institutes of Health study team discovered a neurochemical mechanism that explains plateaus in weight loss. The researchers’…
When glucagon-like peptide-1 receptor agonists are used, patients report an unanticipated change in behavior. Many people report experiencing an…
Polycystic ovary syndrome and endometriosis represent prevalent gynecologic conditions. These disorders affect millions of individuals during their reproductive years….
A new study shows that semaglutide might help people drink much less alcohol. This research focused on adults struggling…